Genes2Me Pvt. Ltd. – Genetic Testing and Diagnostic Lab

Prenatal Testing Market enables us to detect the problems associated with the pregnancy.

Prenatal genetic testing is done to know the birth defects such as Down syndrome, Trisomy 13, Trisomy 18 and others that are associated with genetic disorder of an unborn child before birth or during pregnancy.According to World Health Organization, about 2%-5% of all live births, account for up to 30% of pediatric hospital admissions and cause about 50% of childhood deaths in industrialized countries, almost more than half of these deaths could have been avoided with the availability of proper medical equipment and devices for healthcare procedures.

This significant number is expected to act as a driver to the market growth.Prenatal Genetic Testing Market is expected to rise gradually to an estimated value of USD 92.32 billion by 2026, registering a CAGR of 29.2% in the forecast period of 2019-2026 with the annual sales of USD 11.89 billion in year 2018.Prenatal Genetic Testing Market report has been formulated with a meticulous market analysis that is performed by a team of industry experts, skilful analysts, dynamic forecasters and knowledgeable researchers.

The market study of this report estimates the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors.

This Prenatal Genetic Testing Market report is the best source to bring about unparalleled insights and acquaintance of the best market opportunities into the relevant markets.

Additionally, businesses can accomplish great benefits with this information to come to a decision on their production and marketing strategies.Click Here to Get Sample Report of Prenatal Genetic Testing Market @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-prenatal-genetic-testing-marketMarket Drivers and Restraints:Increasing prevalence of genetic diseases such as down syndrome, edward syndrome and patau syndrome and rising awareness among population.Rising demand for prenatal testing for identifying genetic abnormalities.Increasing approaches for novel diagnostic techniques and tools.High test costs make it unaffordable for the middle class people.High skilled professionals are required.The major players covered in the Prenatal Genetic Testing MarketFew of the major competitors currently working in the dosage cups market are Bio-Rad Laboratories Inc. (US), Agilent Technologies Inc. (US), Illumina, Inc (US), Natera Inc. (US) Abbott (US), Cepheid (US), ELITech Group (France), Autogenomics (US),   Sequenom (US), GeneDx (US), 23andMe, Inc. (US), Ambry Genetics (US), Invitae Corporation (US), Pathway Genomics (US), Progenity, Inc. (US), and few among others.Major TOC Of The ReportChapter One: Prenatal Genetic Testing Market OverviewChapter Two: Manufacturers ProfilesChapter Three:  Global Prenatal Genetic Testing Market  Competition, by PlayersChapter Four: Global Prenatal Genetic Testing Market Size by RegionsChapter Five: North America Prenatal Genetic Testing Market Revenue by CountriesChapter Six: Europe Prenatal Genetic Testing Market Revenue by CountriesChapter Seven: Asia-Pacific Prenatal Genetic Testing Market Revenue by CountriesChapter Eight: South America Prenatal Genetic Testing Market Revenue by CountriesNew Business Strategies, Challenges & Policies are mentioned in Table of Content, Get Download Detailed TOC athttps://www.databridgemarketresearch.com/toc/?dbmr=global-prenatal-genetic-testing-marketKey Report HighlightsComprehensive pricing analysis based on different product types and regional segmentsMarket size data in terms of revenue and sales volumeDeep insights about regulatory and investment scenarios of the Prenatal Genetic Testing Market    Analysis of market effect factors and their impact on the forecast and outlook of the Prenatal Genetic Testing Market    The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the Prenatal Genetic Testing Market    A roadmap of growth opportunities available in the Prenatal Genetic Testing Market    with the identification of key factorsThe exhaustive analysis of various trends of the Prenatal Genetic Testing Market    to help identify market developmentsAccess Full Report @  https://www.databridgemarketresearch.com/reports/global-prenatal-genetic-testing-marketKey Questions Answered in Report:What is the key to the Prenatal Genetic Testing Market?What will the Prenatal Genetic Testing Market Demand and what will be Growth?What are the latest opportunities for Prenatal Genetic Testing Market in the future?What are the strengths of the key players?Browse Related Reports@Mass Spectrometry Software MarketMedication Delivery Systems MarketPDX Models MarketAbout Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.

The Preimplantation Genetic Testing Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.

This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the preimplantation genetic testing market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., CooperSurgical, Inc., Beijing Genomics Institute, Abbott Laboratories, Natera, Inc., Genea Limited, Rubicon Genomics, Inc., Oxford Gene Technology.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Preimplantation Genetic Testing Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/preimplantation-genetic-testing-market/download-sampleMarket DynamicsThe global foot-operated control panel for the elevator market is projected to grow at a significant pace during the forecast period.

A foot-operated control panel was invented with a concern towards a disabled person.

But soon, the picture is predicted to be changing.

Factors such as the growing rate of infertility across the globe, increasing public-private investments in the field of preimplantation genetic testing, rising number of fertility clinics worldwide, technological advancements in the field of genetic analysis, and high risk of chromosomal abnormalities in the fetus with increasing maternal age are driving the growth of this market.The report Preimplantation Genetic Testing Market is projected to reach USD 541.8 Million by 2022 from USD 336.4 Million in 2017, at a CAGR of 10.0%.Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=605              The preimplantation genetic screening segment accounted for the largest share of the market in 2016By type, the preimplantation genetic screening segment accounted for the largest share of the market.

The large share of this segment can primarily be attributed to the decrease in female fertility (due to rising maternal age), increasing prevalence of genetic disorders in offspring, and benefits of PGS, such as increased chances of healthy pregnancy across all age groups, better implantation rate, reduced risks of miscarriage, reduced IVF cycle time, and comprehensive analysis of all 24 chromosome types.By application, the aneuploidy segment is expected to be the fastest growing segment in the forecast periodThe aneuploidy segment is expected to grow at the fastest CAGR.

Growth of this segment can be attributed to the increasing maternal age, rising incidence of aneuploidy disorders, and strategic initiatives by key players to provide technologically advanced PGS products for aneuploidy screening.

Aneuploidy screening has been reported to increase the chance of successful embryo implantation, decreases miscarriage rate, and reduce the chance of having a child with a chromosome abnormality).North America dominated the market in 2016Geographically, the preimplantation genetic testing market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.

North America accounted for the largest share of the market in 2016, followed by Europe.

Rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS), and increasing private-public funding to develop and commercialize novel PGS & PGD procedures are the key factors that account for the larger share of the preimplantation genetic testing market in North America.Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=605As of 2016, the major product manufacturers operating in the global market included Illumina, Inc. (U.S.), CooperSurgical, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abbott Laboratories (U.S.), Natera, Inc. (U.S.), Rubicon Genomics, Inc. (U.S.), Oxford Gene Technology (U.K.), Yikon Genomics (China), and SciGene Corporation (U.S.), among others.

In case the test was carried out for diagnostic functions, the outcomes will typically be reviewed with you by the health care provider who ordered the test.

It’s below Because the nineteen fifties, nevertheless the exorbitant price tag held the test away from the attain from the masses.

To solve these mysteries and give patients far better details, the U.S. government several years back served type and fund ClinVar, a databases for scientists throughout the world to pool gene conclusions, coded to maintain patients' identities private.

Predicting which individuals are at risk for developing advanced AMD is tough since there are numerous threat elements that lead to this condition including age, gender, and genetics along with diet plan, sun exposure and using tobacco.

Should your pharmacogenomic test results counsel you might not have an excellent response to a medication, your members of the family may have an analogous reaction.

NutriPATH practices in the usual practitioner-referral procedure for pathology laboratories.Clients are remarkably advisable to seek the supervision and guidance of a qualified Health care practitioner to the interpretation of any lab final results and linked details.